Skip to search formSkip to main contentSkip to account menu

Cancer Stemness Kinase Inhibitor BBI503

Known as: BBI503 
An orally available cancer cell stemness kinase inhibitor with potential antineoplastic activity. Even though the exact target has not been fully… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Long-noncodingRNAs (lncRNAs) have been proposed as a critical regulator of various cellularprocesses including cell fate decision… 
2017
2017
Introduction: Cardiac progenitor cells (CPCs) possess incredible repair properties in the neonatal heart but are prone to disease… 
Review
2016
Review
2016
This review surveys trialed therapies and molecular defects in adenoid cystic carcinoma (ACC), with an emphasis on neural crest… 
2015
2015
3615 Background: Targeting cancer stem cells (CSC) has shown pre-clinical efficacy and holds therapeutic promise. BBI503 is a… 
2015
2015
The incidence of acute kidney injury in patients with diabetes is significantly higher than that of patients without diabetes… 
2015
2015
BACKGROUND SOX2 is one of the pluripotency transcription factors expressed by stem cells, which plays a central role in…